PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3–4, 2011, Rockville, MD

Arifa S. Khan; Anthony Lubiniecki; Kathryn E. King

doi:10.5731/pdajpst.2012.00895

Research ArticleConference Report

PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3–4, 2011, Rockville, MD

Arifa S. Khan, Anthony Lubiniecki and Kathryn E. King

PDA Journal of Pharmaceutical Science and Technology November 2012, 66 (6) 502-511; DOI: https://doi.org/10.5731/pdajpst.2012.00895

Arifa S. Khan

1Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland 20892;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: Arifa.Khan@fda.hhs.gov

Anthony Lubiniecki

2Pharmaceutical Development & Manufacturing Sciences, Janssen Research & Development, LLC, Malvern, Pennsylvania 19355; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kathryn E. King

3Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland 20892

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
References
Info & Metrics
PDF

Article Information

vol. 66 no. 6 502-511

DOI

https://doi.org/10.5731/pdajpst.2012.00895

PubMed

23183646

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online November 26, 2012.

Author Information

Arifa S. Khan1,*,
Anthony Lubiniecki2 and
Kathryn E. King3

¹Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland 20892;
²Pharmaceutical Development & Manufacturing Sciences, Janssen Research & Development, LLC, Malvern, Pennsylvania 19355; and
³Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland 20892

↵* Correspondence author: Arifa S. Khan, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, MD 20892. Arifa.Khan{at}fda.hhs.gov

View Full Text

Cited By...

4 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection

Arifa S. Khan, Siemon H. S. Ng, Olivier Vandeputte, Aisha Aljanahi, Avisek Deyati, Jean-Pol Cassart, Robert L. Charlebois, Lanyn P. Taliaferro, Katherine McMahon

mSphere 2017 2 5
Report of the international conference on next generation sequencing for adventitious virus detection in biologicals

Arifa S. Khan, Luca Benetti, Johannes Blumel, Dieter Deforce, William M. Egan, Ivana Knezevic, Philip R. Krause, Laurent Mallet, Dietmar Mayer, Philip D. Minor, Pieter Neels, Guanhua Wang

Biologicals 2018 55
Use of tangential flow filtration for improving detection of viral adventitious agents in cell substrates

Vyacheslav A. Furtak, Alena Dabrazhynetskaya, Dmitriy V. Volokhov, Vladimir Chizhikov

Biologicals 2015 43 1
Evaluation of next-generation sequencing performance for in vitro detection of viruses in biological products

Takamasa Hirai, Kiyoko Kataoka, Yuzhe Yuan, Keisuke Yusa, Yoji Sato, Kazuhisa Uchida, Ken Kono

Biologicals 2024 85

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 66, Issue 6

November/December 2012

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3–4, 2011, Rockville, MD

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 3 + 8 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3–4, 2011, Rockville, MD

Arifa S. Khan, Anthony Lubiniecki, Kathryn E. King

PDA Journal of Pharmaceutical Science and Technology Nov 2012, 66 (6) 502-511; DOI: 10.5731/pdajpst.2012.00895

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3–4, 2011, Rockville, MD

Arifa S. Khan, Anthony Lubiniecki, Kathryn E. King

PDA Journal of Pharmaceutical Science and Technology Nov 2012, 66 (6) 502-511; DOI: 10.5731/pdajpst.2012.00895

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection
Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection
New Technologies and Challenges of Novel Virus Detection
Role of Risk Assessments in Viral Safety: An FDA Perspective

Google Scholar

Main menu

User menu

Search

PDA/FDA Adventitious Agents and Novel Cell Substrates: Emerging Technologies and New Challenges, Nov. 3–4, 2011, Rockville, MD

Article Information

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.